Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing Speech Intelligibility Using Transcranial Alternating Current Stimulation (tACS)

NCT04036630 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT04036630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04036630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing Speech Intelligibility Using Transcranial Alternating Current Stimulation (tACS)
Lead sponsor
University of Zurich
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2020
Completion date
February 28, 2024
Enrollment
190 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

electric stimulation therapy, transcranial magnetic stimulation